Indianapolis, IN, United States of America

Kenneth Jeff Thrasher



 

Average Co-Inventor Count = 3.9

ph-index = 5

Forward Citations = 53(Granted Patents)


Company Filing History:


Years Active: 1997-2017

Loading Chart...
Loading Chart...
Loading Chart...
29 patents (USPTO):Explore Patents

Title: Kenneth Jeff Thrasher: A Pioneer in Pharmaceutical Innovations

Introduction

Kenneth Jeff Thrasher, based in Indianapolis, IN, is a distinguished inventor known for his substantial contributions to the field of pharmaceuticals. With a remarkable portfolio of 29 patents, Thrasher has made significant advancements, particularly in the development of compounds and formulations for the treatment of various diseases, including cancer.

Latest Patents

Thrasher's latest patents showcase his innovative spirit and dedication to improving health care. One of his notable inventions includes the "1-oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamide compounds, formulations containing those compounds, and their use as AICARFT inhibitors in the treatment of cancers." This patent highlights his work on novel compounds that inhibit key pathways in cancer treatment. Additionally, he has developed "compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide," emphasizing his focus on delivery mechanisms that enhance the efficacy of therapeutic peptides.

Career Highlights

Kenneth Jeff Thrasher has had a prominent career, working with reputable companies such as Eli Lilly and Company and Emisphere Technologies, Inc. His experience in these renowned firms has equipped him with the knowledge and resources to drive innovation in drug development.

Collaborations

Thrasher has collaborated with notable colleagues in his field, including Alan David Palkowitz and Brian Stephen Muehl. These partnerships have fostered an environment of creativity and research, allowing for the successful realization of various patented technologies and methodologies.

Conclusion

Kenneth Jeff Thrasher's contributions to pharmaceutical innovations through his extensive patent portfolio reflect his commitment to advancing medical science. His work not only demonstrates his individual talent as an inventor but also highlights the importance of collaboration in bringing innovative solutions to the forefront of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…